Status:
UNKNOWN
Evaluation of Clinical and Bone Density Improvement After Implantation of Allogenic Mesenchymal Stem Cell From Umbilical Cord on Osteoporosis Patients
Lead Sponsor:
Ahmad Jabir Rahyussalim
Conditions:
Osteoporosis
Eligibility:
All Genders
40+ years
Phase:
PHASE2
Brief Summary
This study will assess the effectiveness of the allogeneic mesenchymal cell from umbilical cord in improving the quality and quantity of spinal density of osteoporosis patients proven by the results o...
Detailed Description
Currently, preventive and therapeutic strategies for osteoporosis patients are based on calcium and vitamin D supplementation, the use of pharmacological agents that inhibit bone resorption such as bi...
Eligibility Criteria
Inclusion
- Male patients older than 50 yrs old.
- Female patients older than 40 years old.
- Patients enrolled in Cipto Mangunkusumo Hospital with osteoporosis confirmed by BMD test.
- Patients with no history of autoimun disease (SLE, Addison's disease, Chron's disease) and other diseases related to osteoporosis.
- Patients with no history of consuming drug related osteoporosis.
- No active infection confirmed by HbsAg, HIV, CMV, Rubella and Toxoplasma examination.
- Agree to participate the study by signing informed consent form.
Exclusion
- Patients with autoimun diesasde (SLE, Addison's diesase, Chron's disease and other osteoporosis related disease.
- Patients under immunosuppressive, anticoagulant or corticosteroid treatment.
- Paralysis patients after surgical treatment
- Patients under 20 years old
- Declined to participate in the study
Key Trial Info
Start Date :
August 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2020
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT04501354
Start Date
August 1 2020
End Date
December 1 2020
Last Update
August 7 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cipto Mangunkusumo Hospital
Jakarta Pusat, DKI Jakarta, Indonesia, 10430